Poll Suggests Drug Problems for the UK Market

A poll of major firms suggests that European countries will be prioritised over Britain after NHS bosses decided that expensive drugs should be delayed. Leading pharmaceutical firms also believe that cancer drugs will be most strongly affected by the changes that have been instigated by the National Institute for Health and Care Excellence and NHS England. The new survey of 32 members of the Association of the British Pharmaceutical Industry (ABPI) found that 71% believe their companies will... Readmore

Ibuprofen Linked with Heightened Risk of Cardiac Arrest

Researchers in Denmark have suggested that the painkiller ibuprofen can increase the risk of cardiac arrest occurring. This has lead to calls for the sale of the drug to be limited. The new study suggests that taking ibuprofen on a regular basis can increase the risk of cardiac arrest by 31%. Findings published in the European Heart Journal also suggest that other painkillers from the same non-steroidal anti-inflammatory drugs (NSAIDs) can present an even higher risk. Diclofenac, available... Readmore

New £20 Million Drug Cap to be Introduced in England

Health chiefs have announced a massive drugs cap with the intention of saving money for the English healthcare system. A £20 million figure will be set in an attempt to ensure that NHS England reduces its financial deficit. While the cuts will have fiscal benefits for the NHS, experts are already concerned about the implications for the availability of medicine. It is already suggested that this new initiative could lead to delays of up to three years before new drugs are available to NHS patients. This... Readmore

Arbitrary Rationing Measures Must be Lifted NHS Authorities Rule

Health officials have ordered arbitrary rationing measures, responsible for restricting NHS surgery to those most in pain, to be lifted. NHS England has informed clinical commissioning groups across the NHS system that they should cease from denying knee and hip operations to patients based on inappropriate criteria. Current arrangements often result in surgery being denied to any other than those in the worst possible discomfort. Health officials have chosen to intervene in the matter following... Readmore

New Anti-malaria Drug Created in Cardiff

Researchers in Cardiff have developed a new "highly-efficient" method of manufacturing disease-fighting compounds. While this innovation may have multiple benefits in the future, an anti-malaria drug that has resulted from the process has been an early benefit. Sesquiterpenes, found in spicy foods, plants and beer, can be synthesised more quickly as a result of this new research, delivering more cost-effective treatments than was possible previously. The team from Cardiff University proclaim... Readmore

Revolutionary Breast Cancer Drug Set to be Rejected for NHS Usage

The authorities have announced that a revolutionary breast cancer drug will be rejected for use on the NHS. Experts have been hugely critical of the decision regarding palbociclib, suggesting that it is indicative of serious problems at the heart of the drug appraisal system. Following the announcement, there have been calls for the NHS drugs watchdog to be urgently overhauled in order to prevent a repeat of this unenviable decision. Palbociclib halts the most common form of breast cancer,... Readmore

European Cancer Congress Finds Massive Drug Price Inflation

The European Cancer Congress has discovered that prices being charged for generic cancer drugs have risen extremely rapidly in Britain over the last five years. This unwelcome phenomenon is restricting the application and utilisation of such medicines within the NHS system. Drugs such as tamoxifen and bulsufan can be up to 1,000% pricier once they are no longer under patent. Commenting on the issue, the British Generic Manufacturers Association confirmed that it is a common for trusts to pay far more... Readmore

New Pancreatic Cancer Drugs Can Extend Survival

A new study has discovered that a combination of pancreatic cancer drugs can extend the survival of patients. Results of a major trial combining two chemotherapy drugs led to calls for this approach to become the standard approach to treating the debilitating condition. The trial demonstrated that patients lived 2.5 months longer if they took two drugs, as opposed to the usual approach. This is considered particularly valuable, as pancreatic cancer is especially virulent. Data garnered... Readmore

20% of Medicines Set to be Rationed

New NHS plans could lead to 20% of new medicines being rationed. The ethos behind this approach is to save the ailing health service money, but the reality could be that patients are forced to queue for vital treatment. Cancer, diabetes and asthma patients are particularly likely to be affected by the plans. And reports have indicated that this new approach will even affect drugs that have been considered cost-effective by medics. All NHS patients currently have the rights to be treated... Readmore

Patients Illegally Selling NHS-prescribed Medications on Ebay

A BBC investigation has discovered that it is regular practice for NHS patients to sell illegally prescribed medication through online services such as eBay. In response to the investigation, a spokesperson on behalf of eBay indicated that the site has removed numerous illegal items. But it is clear that this practice has occurred on a pretty wide scale throughout the country. Under the terms of The Medicines Act 1968, most medicines can only be sold or supplied against a prescription at a pharmacy... Readmore

FOI Reveals that NHS Spent £100,000 Fighting PrEP Prescriptions

Evidence has revealed that NHS England spent in excess of £100,000 fighting against the funding of the HIV prevention drug PrEP. The data was acquired from a Freedom of Information request filed by Buzzfeed. Pre-exposure prophylaxis, the drug more commonly referred to as PEP, can reduce the chances of being infected by HIV if taken on a daily basis. Much of this extortionate amount of money has been derived from a high-profile court case, in which NHS England was ultimately forced to pay both... Readmore

New MS Drug Ocrelizumab Considered ‘Big News’ by Charities and Experts

Doctors and charities have hailed a drug that alters the immune system, believing that it could represent a major breakthrough in the treatment of multiple sclerosis. Trials published in the New England Journal of Medicine suggest that Ocrelizumabcan slow damage to the brain in two forms of MS. The drug is the first that has been demonstrated to work in the primary progressive form of MS. Ocrelizumab is currently being reviewed with a view to making the drug available in the US and Europe. The... Readmore
This site uses cookies. Find out more about this site’s cookies.